Value-Based Pricing

Linking Prices to Benefits

Pricing drugs based on value can make drug spending more sustainable and reward innovators for products that improve patients’ lives. Schaeffer Scholars are advancing strategies to align payments for drugs with the benefits they provide to patients.

Top Stories View All

News

Analysis Finds Meaningful Impact on Pharmaceutical Innovation From Reduced Revenues

For every 10% reduction in expected U.S. revenues, pharmaceutical innovation is expected to decline by up to 15%, finds a new Schaeffer Center analysis. Policymakers should consider whether lowering drug prices risks undermining long-term population health.

Featured Experts: Darius Lakdawalla, Dana Goldman, Karen Van Nuys

White Paper

The Elasticity of Pharmaceutical Innovation: How Much Does Revenue Drive New Drug Development?

Perspective

How To Advance The Debate Over QALYs: A Response To Kaplan et al.

Issue Briefs

A New Healthcare Valuation Model That Puts Patients First: Generalized Risk Adjusted Cost-Effectiveness (GRACE)

In The News View All

STAT